A new publication on ecnoglutide appeared on September 11, 2026, in the journal Frontiers in Endocrinology. The paper, titled "Dose-response and time-course effects of ecnoglutide in type 2 diabetes: a systematic review and meta-analysis of efficacy," presents a systematic review and meta-analysis. Ecnoglutide remains an unapproved compound currently in research use. The publication is indexed under PubMed ID 42798476 and is available through PubMed. This brief reports only that the publication exists and describes its stated focus, without summarizing specific findings or results. Readers interested in the broader context of ecnoglutide, including its regulatory status and research background, can consult the compound overview for additional information.
New Publication: Ecnoglutide Meta-Analysis on Dose-Response in Type 2 Diabetes
See the full ecnoglutide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42798476/